We continue working to develop and obtain the Food and Drug Administration (FDA) authorization to market potentially reduced risk tobacco products and provide truthful and accurate communications about them to adult tobacco consumers.

In support of this work we regularly engage with the scientific, public health, and regulatory communities through face-to-face meetings, regulatory filings, publishing in scientific journals and participating at scientific conferences where we present our research. We listen to and welcome feedback on our work.

Reach Out

We are always interested in hearing from other scientists and stakeholders. If you have questions, would like to provide feedback on our work, or learn more about our research and our approach to harm reduction, contact us today.

Paige Magness Photo

Paige Magness

Senior Vice President, Regulatory Affairs

"For decades we have been committed to offering adult smokers better alternatives and ensuring a regulatory framework to determine if those products offer lower risk and how to appropriately communicate about them. We’re fully engaged in the science, policy and regulatory dialogue necessary to innovate and deliver acceptable alternatives adult smokers need and want."

Coresta Logo

CORESTA Smoke-Techno Presentations Available

The CORESTA Smoke-Techno virtual conference has concluded. We delivered 11 presentations on smoke science and product technology. Follow the link to see the presentations.

Maria Gogova Photo at TSR

Dr. Maria Gogova Delivers Keynote Address at 2021 TSRC

Read our Chief Scientific Officer’s comments about "The Path Forward on Harm Reduction" delivered on August 30th at the Tobacco Science Research Conference.

Accompanying Slides

Global Tobacco & Nicotine Forum's virtual "THR in Focus"

On April 27th, Dr. Maria Gogova presented at the Global Tobacco & Nicotine Forum’s virtual "THR in Focus" program. Maria was joined by a diverse group of stakeholders on a panel to address the topic "The Evidence for Tobacco Harm Reduction: Dispelling the Myths."

Recent Publication

Estimating the Population Health Impact of Recently Introduced Modified Risk Tobacco Products: A Comparison of Different Approaches.